Status | Study |
NOT_YET_RECRUITING |
Study Name: UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study Condition: Date: 2023-05-29 Interventions: The level of CIN The extracted DNA from urine exfoliated cells will be analyzed by UroCAD to determine the level of CIN. |
Recruiting |
Study Name: Multi Institutional Study in Patient Presenting With Hematuria Condition: Bladder Cancer Hematuria Date: 2017-04-12 Interventions: Diagnostic Test: AssureMDx combined panel of methylation and mutation markers for the detection of bladd |
Recruiting |
Study Name: Urine-DNA Biomarkers in Detecting Bladder Cancer Condition: Bladder Cancer Biomarker Diagnosis Date: 2017-02-20 Interventions: Diagnostic Test: Next generation sequencing The obtained DNA from the urine, blood and tumor (optional) |
Recruiting |
Study Name: Scanadu Urine Device Validation Study Protocol Condition: Urinary Tract Infections Proteinuria Ketone Urine Date: 2016-11-15 Interventions: Device: Scanadu Urine Device Device to allow lay user to perform urinalysis test at home. |
Recruiting |
Study Name: Vaginal Estrogen for Asymptomatic Microscopic Hematuria Condition: Asymptomatic Microscopic Hematuria Date: 2016-10-19 Interventions: Drug: Estradiol Ring Other Name: Estring |
Recruiting |
Study Name: Detecting Bladder Cancer Using the UroMark Test. Condition: Bladder Cancer Date: 2015-12-18 Interventions: Other: Group Other Name: Observational |
Recruiting |
Study Name: Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease Condition: Nephritis, Hereditary Alport Syndrome Alport Syndrome, Aut Date: 2015-11-10 |
Completed |
Study Name: Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer Condition: Urinary Bladder Neoplasms Sexual Dysfunction, Physiological Date: 2015-03-05 Interventions: Other: EORTC QLQ-C30 and EORTC BLS-24 questionnaire Questionnaires answered at baseline and 4 months fol |
Recruiting |
Study Name: European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome Condition: Alport Syndrome Hereditary Kidney Disease Pediatric Kidney Date: 2015-02-26 Interventions: Drug: ACE-inhibitor observatio |
Enrolling by invitation |
Study Name: Peri-operative Aspirin Continuation Versus Discontinuation Condition: Hematuria Urinary Bladder Neoplasms Date: 2015-01-26 Interventions: Drug: Aspirin Other Name: Acetylsalicylic acid |